SRPTCommon stockNASDAQ
SRPT Common stock
This is the ticker-level security page. The issuer is Sarepta Therapeutics.
Security details
Issuer financial context
These figures belong to the issuer company, not to this security itself.
Revenue TTM
$2.4B
Net income TTM
-$271.5M
Total assets
Not available
Total debt
Not available
Total equity
Not available
Profit margin
-11.3%
ROE
-20.6%
ROA
-7.8%
Latest issuer financial snapshot: 2024-12-31